Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
164.70B
Market cap164.70B
Price-Earnings ratio
41.32
Price-Earnings ratio41.32
Dividend yield
5.95%
Dividend yield5.95%
Average volume
41.05M
Average volume41.05M
High today
$28.99
High today$28.99
Low today
$28.62
Low today$28.62
Open price
$28.96
Open price$28.96
Volume
21.60M
Volume21.60M
52 Week high
$31.44
52 Week high$31.44
52 Week low
$23.62
52 Week low$23.62

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $28.93. The company's market cap stands at 164.7B, with a P/E ratio of 41.32 and a dividend yield of 5.95%.

On 2026-11-14, Pfizer(PFE) stock moved within a range of $28.62 to $28.99. With shares now at $28.93, the stock is trading +1.1% above its intraday low and -0.2% below the session's peak.

Trading activity shows a volume of 21.6M, compared to an average daily volume of 41.05M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.

PFE News

The Motley Fool 4h
Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?

As the global health landscape shifts toward obesity treatments, investors are weighing the rapid growth of Novo Nordisk A/S (NVO +2.41%) against the deep-roote...

Novo Nordisk vs. Pfizer: Does a Weight Loss or Cancer Focused Pharma Stock Make a Better Buy for 2027?
The Motley Fool 12h
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?

Pfizer (PFE +0.21%) and AbbVie (ABBV +0.20%) rank among the biggest drugmakers in the world. Both pharma stocks have also been favorites for many income investo...

Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?
Simply Wall St 20h
Pfizer Stock Looks Above Fair Value As Shares Rebound

has climbed back this year after a difficult five year stretch, which raises a simple question for anyone looking at the ticker today. Is the current share pric...

Pfizer Stock Looks Above Fair Value As Shares Rebound

Analyst ratings

61%

of 28 ratings
Buy
28.6%
Hold
60.7%
Sell
10.7%

More PFE News

The Motley Fool 1d
Pfizer Just Raised Its 2026 Revenue Forecast by $1.5 Billion. Is the High-Yield Stock a Buy Right Now?

Pfizer (PFE +0.00%) has a huge 5.8% dividend yield. That compares to roughly 1% for the broader market and 1.3% for the average pharmaceutical stock. Pfizer's s...

Pfizer Just Raised Its 2026 Revenue Forecast by $1.5 Billion. Is the High-Yield Stock a Buy Right Now?
Benzinga 1d
Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market

Pfizer Inc. (NYSE:PFE) will reportedly no longer sell its hormone replacement therapy Premarin in Canada following an internal review, ending Canadian availabil...

Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market
24/7 Wall St. 1d
A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

A Record-High Dividend Yield Can Be a Warning Sign. Just Ask Pfizer
Simply Wall St 2d
Pfizer Secures $1.5 Billion For Obesity Drug Development

Pfizer (NYSE:PFE) entered a funding partnership with Blackstone Life Sciences to advance its investigational obesity drug berobenatide. Blackstone agreed to co...

Pfizer Secures $1.5 Billion For Obesity Drug Development
TipRanks 2d
Pfizer Kidney Cancer Trial Ends After Limited Enrollment in Combination Arms

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. (NYSE: PFE) has updated NCT05935748, a Phase 2 study titled “...

24/7 Wall St. 2d
Blackstone Is Paying Up to $1.5 Billion for Pfizer’s Answer to Wegovy

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Blackstone Is Paying Up to $1.5 Billion for Pfizer’s Answer to Wegovy
Benzinga 2d
Blackstone Bankrolls Pfizer’s Weight Loss Drug Trials for Slice of Future Sales

Pfizer Inc. (NYSE:PFE) and Blackstone Life Sciences on Wednesday announced a strategic co-funding agreement under which Blackstone will pay up to $1.5 billion i...

Blackstone Bankrolls Pfizer’s Weight Loss Drug Trials for Slice of Future Sales

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.